Enumeration of CTCs may be useful for determining long-term prognosis in patients with metastatic castration-sensitive prostate cancer and breast cancer.
Read MoreInVisionFirst-Lung is a ctDNA next-generation sequencing liquid biopsy assay testing 37 genes relevant to the care of advanced NSCLC patients.
Read MoreArcherDx plans to leverage the personalized cancer monitoring assays to develop companion diagnostics for AstraZeneca’s associated immunooncology therapies.
Read More
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read MoreStratafide genomic testing helps community hospitals deliver accurate and actionable genomic information to cancer patients and providers.
Read More